Multiple myeloma

NHS England first to offer ‘trojan horse’ therapy to fight blood cancer

NICE have just approved the new treatment, which could slow down progression for multiple myeloma patients

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP